Muir-Torre syndrome
Muir-Torre Syndrome (MTS) is a subtype of Lynch syndrome. It is an inherited condition that increases a person’s lifetime risk for developing rare types of skin, colorectal, and genitourinary tract cancers.
The facts
- Muir-Torre Syndrome (MTS) is an inherited disorder sometimes found in people with colorectal cancer.
- As with Lynch syndrome, MTS is caused by an inherited harmful change (mutation) in one of the DNA mismatch repair (MMR) genes.
- The mutation is passed from one generation to the next, and in a family with a parent who has an inherited change in their DNA, each child has 50% of being diagnosed with MTS.
The MLH1 and MSH2 genes are most commonly mutated in MTS patients.

Skin cancer and MTS
The presence of specific types of skin or internal cancers are the primary symptoms of MTS.
Skin Cancers
- Sebaceous adenoma is the most frequent symptom in people with MTS (80-99%).
- Sebaceous carcinoma of the eyelid is an aggressive cancer that spreads to the eye orbit and can be fatal.
- Additional skin cancers include sebaceous epitheliomas and keratoacanthomas.

Internal cancers
- 30-79% of MTS patients have colon cancer or stomach cancer.
- 5-29% of MTS patients have endometrial (uterine) or breast cancer.
- About 60% of people with MTS develop metastatic disease.

Diagnosis and risks
Since MTS is a subtype of Lynch syndrome, the diagnosis, risk factors, and treatment of this disorder is very similar.
Looking for some support?
My BlueHQTop resources

In Shawn’s corner: Stepping into the ring to end CRC
Shawn has lived with Crohn’s disease since age 10, a condition that raises his risk of colorectal cancer. He’s stepping into the ring with Haymakers for Hope to help end this disease, and he wants you in his corner.

FDA approves Tecentriq for some people with stage III colon cancer
The FDA has approved Tecentriq (atezolizumab), given with chemotherapy after surgery, for people with stage III colon cancer whose tumors are mismatch repair deficient (dMMR). It’s the first immunotherapy approved for this use.

He almost skipped the colonoscopy that saved his life
Andy said his lifestyle made it easier to ignore the blood in the stool, a symptom of colorectal cancer. But the “mirage of invincibility,” as he called it, was about to vanish.




